Likewise, co-administration of ginsenoside Rg1 and astragaloside IV inhibits diabetic nephropathy-related renal fibrosis through suppression of oxidative stress and the TGF-β1/Smads signaling pathway (Du et al., 2018). The gene discussed is TGFB1; the disease is diabetic kidney disease.